Their results, which were published in Nature Communications 25 March, could help the biotech industry to optimize microbial production of useful molecules and help in drug design. Border control ...

Foreign parties to cross-border biotech transactions have ... category when one or more technologies such US biotech company produces, designs, tests, manufactures, fabricates or develops are ...

A three-day international workshop on priority areas in 'biotechnology across borders' is being organized by Council for Scientific and Industrial Research’s National Chemical Laboratory between ...

Genenta (www.genenta.com) is a clinical-stage biotechnology company engaged in the development of a proprietary hematopoietic stem cell therapy for the treatment of a variety of solid tumor cancers.